Search results

Filter (5 in use)

Type 4 selected

  • Remove filter for NICE advice (1)
  • Remove filter for NICE Pathways
  • Remove filter for News
  • Remove filter for Research recommendations

Last updated

  • Filter by Last 3 months
  • Filter by Last 6 months
  • Filter by Last year
  • Filter by Last 3 years

Advice programme 1 selected

  • Filter by Medtech innovation briefings (5)
  • Remove filter for Evidence summaries (1)
  • Filter by Key therapeutic topics (1)

1 result for Occupational therapy

Sorted by Relevance . | Sort by Date

  • NICE advice Remove NICE advice filter
  • NICE Pathways Remove NICE Pathways filter
  • News Remove News filter
  • Research recommendations Remove Research recommendations filter
  • Evidence summaries Remove Evidence summaries filter
  1. Scleroderma: oral mycophenolate (ESUOM32)

    Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making

    Type
    Evidence summary
    Published
    29 July 2014